| S7455 |
Resatorvid (TAK-242)
|
Resatorvid (TAK-242, CLI-095) is a small-molecule-specific inhibitor of Toll-like receptor (TLR) 4 signaling, blocking LPS-induced production of NO, TNF-α and IL-6 in macrophages with IC50 of 1.8 nM, 1.9 nM and 1.3 nM, respectively. This compound downregulates expression of TLR4 downstream signaling molecules MyD88 and TRIF, and it also inhibits autophagy.
|
-
EMBO J, 2025, 10.1038/s44318-025-00515-z
-
Carbohydr Polym, 2025, 350:122980
-
J Neuroinflammation, 2025, 22(1):38
|
|
| S6597 |
TLR2-IN-C29
|
TLR2-IN-C29 (C29) is a Toll-like receptor 2 (TLR2) inhibitor that inhibits TLR2/1 and TLR2/6 signaling.
|
-
Protein Cell, 2025, pwaf020
-
J Neuroinflammation, 2025, 22(1):38
-
Int J Biol Macromol, 2025, 284(Pt 2):138092
|
|
| S8677 |
CU-CPT22
|
CU-CPT22 shows dose-dependent inhibitory effects blocking Pam3CSK4-induced TLR1/2 activation with an IC50 of 0.58 ± 0.09 µM while no significant inhibition to TLR2/6. It demonstrates minimal non-specific inhibition against a panel of 10 representative kinases (PDGFRB, MET, DDR2, SRC, MAPK1, PAK1, AKT1, PKC-γ, CAMK1, and PLK4).
|
-
EMBO Rep, 2025, 10.1038/s44319-025-00558-7
-
Cancer Cell, 2024, S1535-6108(24)00135-1
-
J Exp Clin Cancer Res, 2023, 42(1):172
|
|
| S0716 |
E6446
|
E6446 is an inhibitor of Toll-like receptor (TLR) 7 and 9 signaling in a variety of human and mouse cell types and inhibits DNA-TLR9 interaction in vitro.
|
-
Mol Ther Nucleic Acids, 2025, 36(4):102743
-
Cancer Cell, 2024, S1535-6108(24)00135-1
-
Front Immunol, 2024, 15:1354055
|
|
| S6719 |
E6446 Dihydrochloride
|
E6446 dihydrochloride is a specific Toll-like receptor 9 inhibitor.
|
-
Int J Biol Sci, 2025, 21(13):5762-5781
-
Cell Death Dis, 2025, 16(1):60
-
Diabetes, 2025, 74(3):409-415
|
|
| S6573 |
MD2-IN-1
|
MD2-IN-1 is an inhibitor of Myeloid differentiation protein 2 (MD2) with a KD value of 189 μM.
|
-
Life Sci Alliance, 2023, 6(3)e202201636
-
Front Immunol, 2022, 13:995791
-
Br J Pharmacol, 2021, 10.1111/bph.15412
|
|
| S8562 |
IRAK4-IN-2
|
IRAK4-IN-2 is a reversible kinase inhibitor that modulates IRAK4 function in both the toll-like receptor (TLR) and interleukin 1 receptor (IL-1R) signaling cascades.
|
-
Cancer Letters, 2021, 75-90
-
Cancer Lett, 2021, 503:75-90
|
|
| E5812 |
AT791
|
AT791 is a potent and orally bioavailable inhibitor of TLR7 and TLR9 with an IC50 of 3.33 μM and 0.04 μM, respectively, in human embryonic kidney cells and also inhibits DNA-TLR9 interaction in vitro.
|
|
|
| E7077 |
DSRM-3716
|
DSRM-3716 (5-Iodoisoquinoline, Compound 6) is a potent and selective inhibitor of SARM1 with an IC50 of 75 nM. It robustly blocks axonal degeneration by preventing cADPR elevation following axotomy or mitochondrial stress.
|
|
|
| E5922New |
Enpatoran
|
Enpatoran is a potent, selective inhibitor of Toll-like receptors 7 and 8 (TLR7/8), with IC50 of 11.1 nM and 24.1 nM, respectively, in HEK293 cells. It also demonstrates potential for treating autoimmune diseases.
|
|
|
| E2758New |
Robinin
|
Robinin is a flavonoid that acts by inhibiting TLR4/NF-κB and TLR2-PI3k-AKT signaling pathways. Robinin reduces oxidized-LDL-induced TLR2 and TLR4 expression at the mRNA level and prevents NF-κB p65 nuclear translocation by regulating TLR-NF-κB signaling. Robinin exhibits anti-inflammatory and anti-tumor effects.
|
|
|
| S9931 |
Enpatoran Hydrochloride
|
Enpatoran (M5049) hydrochloride is a potent, orally active, and dual TLR7/8 inhibitor with IC50s of 11.1 nM and 24.1 nM, respectively, in HEK293 cells.
|
|
|
| S0139 |
MD2-TLR4-IN-1
|
MD2-TLR4-IN-1 (Compound 22m) is a potent inhibitor of myeloid differentiation protein 2/toll-like receptor 4 (MD2-TLR4). This compound inhibits lipopolysaccharide (LPS)-induced expression of tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) in macrophages with IC50 of 0.89 μM and 0.53 μM, respectively.
|
|
|
| S6999 |
Chloroquine
|
Chloroquine is an antimalarial drug and autophagy/lysosome inhibitor. Chloroquine also suppresses Toll-like receptor-9 (TLR9) protein expression. Chloroquine is highly effective agianst SARS-CoV-2 (COVID-19) infection with EC50 of 1.13 μM in Vero E6 cells. Chloroquine has anti-HIV-1 activity.
|
-
Signal Transduct Target Ther, 2025, 10(1):26
-
Cell Discov, 2025, 11(1):15
-
Cell Metab, 2025, S1550-4131(25)00149-4
|
|
| S4157 |
Chloroquine diphosphate
|
Chloroquine diphosphate is a 4-aminoquinoline anti-malarial and anti-rheumatoid agent, also acting as an ATM activator. Chloroquine is also an inhibitor of toll-like receptors (TLRs).
|
-
Front Vet Sci, 2025, 12:1587391
-
Nat Commun, 2024, 15(1):1642
-
Cancer Lett, 2024, 604:217258
|
|
| S4430 |
HCQ (Hydroxychloroquine) Sulfate
|
Hydroxychloroquine (HCQ) Sulfate is an antimalarial agent used for the treatment of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune, inflammatory and dermatologic conditions. Also acts as an inhibitor of autophagy and toll-like receptor (TLR) 7/9.
|
-
EMBO J, 2025, 10.1038/s44318-025-00581-3
-
iScience, 2025, 28(4):112054
-
Int J Mol Sci, 2025, 26(2)588
|
|
| S3924 |
Ginsenoside Rb1
|
Ginsenoside Rb1 (Gypenoside Ⅲ) is a protopanaxadiol that has diverse in vitro and in vivo effects, including neuroprotective, anti-inflammatory, and anti-obesity actions. This compound, a main constituent of the root of Panax ginseng, inhibits Na+, K+-ATPase activity with IC50 of 6.3±1.0 μM. It also inhibits IRAK-1 activation and phosphorylation of NF-κB p65. This chemical reduces the expressions of TLR3, TLR4 and TRAF-6, and down-regulates the levels of TNF-α, IFN-β and iNOS.
|
-
J Biol Chem, 2024, 300(8):107542
-
J Ethnopharmacol, 2021, S0378-8741(21)00169-0
-
J Biol Chem, 2021, S0021-9258(21)00790-0
|
|
| S6934 |
AMG-9810
|
AMG-9810 is a potent, competitive and selective vanilloid receptor 1 (TRPV1) antagonist and inhibits capsaicin activation with IC50 of 24.5 nM and 85.6 nM for human TRPV1 and rat TRPV1, repectively. This compound blocks all known modes of TRPV1 activation, including protons-, heat-, and endogenous ligands, such as anandamide, N-arachidonyl dopamine, and oleoyldopamine. It significantly reduces the mRNA expression of TLR2 and TLR4. This chemical also promotes mouse skin tumorigenesis mediated through EGFR/Akt/mTOR signaling.
|
-
Int J Mol Sci, 2025, 26(18)8816
-
International Journal of Molecular Sciences, 2025, 8816
-
Journal of Inflammation Research, 2024, 153-170
|
|
| S9234 |
Schaftoside
|
Schaftoside, a bioactive compound found in the Herba Desmodii Styracifolii, exhibits pancreatic lipase inhibitory activity. This compound inhibits the expression of TLR4 and Myd88. It also decreases Drp1 expression and phosphorylation, and reduces mitochondrial fission.
|
|
|
| E3193 |
Saponaria Officinalis Extract
|
Saponaria Officinalis Extract is extracted from Saponaria Officinalis, which reduces downstream inflammatory responses by disrupting the TLR4/MD2 complex and blocking MyD88-dependent inflammatory signaling.
|
|
|
| E1134 |
ABR-238901
|
ABR-238901 is a novel S100A8/A9 blocker that potently inhibits S100A8/A9 interaction with its receptors RAGE (receptor for advanced glycation endproducts) and TLR4 (toll-like receptor 4).
|
|
|
| E0694 |
Okanin
|
Okanin, a chalcone found in the flower tea Coreopsis tinctoria, effectively reduces LPS-induced microglial activation by inhibiting the TLR4/NF-κB signalling pathways. It also reduces LPS-induced nitric oxide (NO) production and iNOS expression by increasing HO-1 expression. It exhibits a potential as a nutritional preventive measure for neurodegenerative disorders.
|
|
|